NEW YORK-PRESBYTERIAN/BROOKLYN METHO
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $1.3M
- Transactions
- 408
- Companies
- 40
- Average per transaction
- $3,250
Who reported the payments
| Siemens Medical Solutions USA, Inc. | $352,431 |
| Abbott | $115,641 |
| Stryker | $108,054 |
| Kls-martin L.p. | $75,752 |
| American Regent | $69,946 |
| Rapid Pathogen Screening, Inc. | $59,890 |
| Cook Incorporated | $58,000 |
| Amgen | $46,280 |
| Boston Scientific | $43,300 |
| Medtronic | $42,745 |
| Biotronik Inc. | $42,521 |
| United Therapeutics Corporation | $36,822 |
| Bayer | $21,936 |
| Aesculap, Inc. | $19,765 |
| Caris MPI, Inc. | $18,788 |
| Acadia Pharmaceuticals Inc | $18,345 |
| GSK | $17,465 |
| Novartis | $16,601 |
| SK Life Science, Inc. | $16,130 |
| Vifor (international) Ltd. | $14,265 |
| Bristol Myers Squibb | $12,500 |
| Novocure Inc. | $12,348 |
| Dova Pharmaceuticals | $12,250 |
| Bausch Health US, LLC | $9,840 |
| Arjo Inc. | $7,500 |
| Roche Products Limited | $7,440 |
| Arrow International, Inc. | $7,250 |
| GE HealthCare | $7,205 |
| Medline Industries LP | $7,109 |
| E.r. Squibb & Sons, L.L.C. | $6,730 |
| AstraZeneca | $6,205 |
| Actelion Pharmaceuticals, Ltd | $5,030 |
| Global Kinetics USA Corporation | $4,500 |
| Livanova USA, Inc. | $3,600 |
| Agios Pharmaceuticals, Inc. | $3,000 |
| Merck | $2,930 |
| AbbVie | $2,690 |
| Linvatec Corporation | $2,350 |
| Merz Pharmaceuticals, LLC | $2,265 |
| Olympus America Inc. | $2,015 |